JUN 28, 2017 09:00 AM HKT
案例研究:扩大细胞治疗生产规模
SPONSORED BY: TERUMO BCT
CONTINUING EDUCATION (CME/CE/CEU) CREDITS: P.A.C.E. CE | Florida CE
4 1 852

Speakers:
  • Senior Cell Processing Specialist, Terumo BCT
    Biography
      Prior to joining the Cell Processing team at Terumo BCT, Dr. Beltzer was the lead scientist for the research and development of Corning® Synthemax®, a synthetic growth surface for the culture of human embryonic stem cells at Corning Life Sciences. He was a co-founder of RETT Corporation and was a key player in the industrialization of several technology platforms, including phage display and yeast two-hybrid. He has more than 20 years of industrial research and development experience in a broad range of disciplines.

    Abstract:

    不好意思,由于遇到技术困难,此网上讨论会延迟到六月二十八日。若此时间对您不方便,您将可事后从网站上电阅。

    DATE: June 28, 2017 
    TIME: 9:00 AM HKT

    OR

    DATE: June 27, 2017
    TIME: 6:00 PM PDT

     

    深入了解使用一个功能性密闭状态的自动化细胞培养流程扩增T细胞、生产病毒载体和扩大间充质干细胞(MSC)生产规模。

     

    可能感兴趣的读者
    • 临床医生、研究者、实验室技术员和细胞治疗行业的专业人士
    • 细胞治疗生产行业的专业人士
    • 基因和免疫治疗生产行业的专业人士
     

    • 使用中空纤维生物反应器系统扩增T细胞的新结果

    • 扩大间充质干细胞(MSC)生产规模的技术

    • 生产病毒载体的新方法

    • 成功节省财力和人力的案例研究


    Show Resources
    Loading Comments...